Congresses

Title Yearsort ascending
KCa3.1-overexpression in skin causes pruritic eczema and epidermal hyperplasi 2019
Invited Talk: Emerging pathogenic roles of KCa3.1 channels in skin disease. 2018
KCa3.1-overexpression in murine intestinal epithelium impairs duodenal motility 2018
Defective Function of KCa3. 1 Channels in Lysosomal Storage Disorders 2017
LA SOBRE-EXPRESIÓN CONDICIONAL DEL CANAL KCa3.1 ALTERA SEVERAMENTE LA MOTILIDAD INTESTINAL EN RATÓN 2017
KCa3.1 channel in endothelial/epithelial cell signaling and as drug target 2017
Lysosomal Storage Disorders as Group Representative 2017
Novel gating modulators of KCa3.1 channels and therapeutic perspectives 2016
DEFICIENCY OF MONOCYTE/MACROPHAGE KCA3.1-FUNCTIONS IN TYPE-1/3 GAUCHER DISEASE 2016
RIC Mitin anual 2015
1. Genetic deficit of KCa3.1 channels protects against edema and pulmonary circulatory collapse caused by TRPV4 activation. 2. Characterization of monocyte/macrophage KCa3.1 channels in Gaucher’s Disease. 3. New negative-gating modulators of KCa2 and KCa 2015
1. Role of SK3 channels in erectile function in mice 2. Genetic deficit of KCa3.1 channels protects against pulmonary circulatory collapse induced by TRPV4 channel activation 2015
Innovative negative gating modulators of kca2/3 potassium channels as new pharmacological tools 2014
NOVEL NEGATIVE GATING MODULATORS OF KCA2/3 POTASSIUM CHANNELS AS PHARMACOLOGICAL TOOLS FOR NOVEL TRATMENSTS 2014
Design and development of novel KCa modulators and utilities in neurological disease 2014
New treatment strategies for Multiple Sclerosis: The MSchannelomics project. 2014
Positive KCa channel gating modulators with selectivity for KCa3.1. 2014
Novel potent small molecule modulators of cardiac KCa2 and KCa3.1 channels: Potential utility for treating cardiac ischemia and atrial fibrillation. 2013
Positive feedback influence of KCa3.1 channels on stimulated endothelial Ca2+ dynamics 2013
SKA-111, a Positive KCa Channel Gating Modulator with Selectivity for KCa3.1 2013

Pages